What are the opening hours?

Monday 09:00 - 18:00 Tuesday 09:00 - 18:00 Wednesday 09:00 - 18:00 Thursday 09:00 - 18:00 Friday 09:00 - 18:00

Oncode Scientific Sdn Bhd

Home
Malaysia
Shah Alam
Oncode Scientific Sdn Bhd

Oncode Scientific Sdn Bhd
201501029484 (1154805-X)

Leading the Precision Medicine Revolution in Asia

Since 2015, Oncode Scientific Sdn Bhd has emerged as a trailblazer in the realm of precision medicine, setting new benchmarks in cancer molecular diagnostics. Our multidisciplinary team, comprising top-tier experts from molecular science and clinical practice, brings together decades of experience in medical diagnostics and research. At our cutting-edge facilities in Malaysia, we spearhead one of Asia’s most pioneering precision medicine initiatives, specializing in both solid tumors and hematologic cancers. Our relentless pursuit of innovation drives us to constantly challenge the status quo, exceeding clinical and diagnostic standards to deliver groundbreaking medical solutions. Oncode is dedicated to transforming healthcare—advancing disease prevention, early detection, and targeted intervention. With a commitment to excellence, we provide world-class molecular diagnostic services that are both accessible and revolutionary, empowering the global community to embrace the full potential of precision medicine.

23/01/2026

𝗜𝗻 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟱, Oncode proudly participated in the 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝟮𝟬𝟮𝟱 at 𝗠𝗲𝗻𝗮𝗿𝗮 𝗕𝗔𝗖, organised by the 𝗣𝗶𝗻𝗸 𝗥𝗶𝗯𝗯𝗼𝗻 𝗪𝗲𝗹𝗹𝗻𝗲𝘀𝘀 (𝗟) 𝗙𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻 in collaboration with 𝗕𝗲𝗮𝗰𝗼𝗻 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹.

The conference brought together 𝗰𝗹𝗶𝗻𝗶𝗰𝗶𝗮𝗻𝘀, 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁𝘀, 𝗮𝗻𝗱 𝗯𝗿𝗲𝗮𝘀𝘁 𝗰𝗮𝗻𝗰𝗲𝗿 𝘀𝘂𝗿𝘃𝗶𝘃𝗼𝗿𝘀 for meaningful discussions on 𝗯𝗿𝗲𝗮𝘀𝘁 𝗰𝗮𝗻𝗰𝗲𝗿 𝗰𝗮𝗿𝗲, bridging clinical expertise with patient-centred perspectives. Through 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝗳𝘂𝗹 𝘁𝗮𝗹𝗸𝘀 𝗮𝗻𝗱 𝗽𝗮𝗻𝗲𝗹 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻𝘀, 𝗰𝗼𝗺𝗺𝗼𝗻 𝗺𝗶𝘀𝗰𝗼𝗻𝗰𝗲𝗽𝘁𝗶𝗼𝗻𝘀 𝘄𝗲𝗿𝗲 𝗮𝗱𝗱𝗿𝗲𝘀𝘀𝗲𝗱, and 𝗸𝗲𝘆 𝘂𝗽𝗱𝗮𝘁𝗲𝘀 𝗿𝗲𝗹𝗲𝘃𝗮𝗻𝘁 𝘁𝗼 𝗽𝗿𝗶𝗺𝗮𝗿𝘆 𝗰𝗮𝗿𝗲 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗲 𝘄𝗲𝗿𝗲 𝘀𝗵𝗮𝗿𝗲𝗱.

Oncode was honoured to contribute to a day of 𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴, 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻, 𝗮𝗻𝗱 𝘀𝗵𝗮𝗿𝗲𝗱 𝗽𝘂𝗿𝗽𝗼𝘀𝗲 in advancing women’s health.

We thank the organisers and participants for making the event truly meaningful.

20/01/2026

𝗘𝗮𝗿𝗹𝘆 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝘀𝘁𝗮𝗿𝘁𝘀 𝘄𝗶𝘁𝗵 𝗮𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 — 𝗮𝗻𝗱 𝗮𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝘀𝘁𝗮𝗿𝘁𝘀 𝘄𝗶𝘁𝗵 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗵𝗮𝘁 𝗺𝗮𝘁𝘁𝗲𝗿.

On 𝟳𝘁𝗵 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟬𝟮𝟱, Oncode was honoured to join 𝘁𝗵𝗲 𝗹𝗮𝘂𝗻𝗰𝗵 𝗼𝗳 𝘁𝗵𝗲 𝗠𝗮𝗺𝗺𝗼𝗴𝗿𝗮𝗺 𝗔𝗱𝘃𝗼𝗰𝗮𝗰𝘆 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 & 𝗣𝗶𝗻𝗸 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗼𝗻 at 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝗶 𝗦𝗮𝗶𝗻𝘀 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮 (𝗨𝗦𝗠) 𝗛𝗲𝗮𝗹𝘁𝗵 𝗖𝗮𝗺𝗽𝘂𝘀, organised by the inspiring team at the 𝗕𝗲𝘀𝘁𝗔𝗥𝗶 𝗨𝗻𝗶𝘁, 𝗨𝗦𝗠 𝗦𝗽𝗲𝗰𝗶𝗮𝗹𝗶𝘀𝘁 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹.

The event brought together 𝗰𝗮𝗻𝗰𝗲𝗿 𝘀𝘂𝗿𝘃𝗶𝘃𝗼𝗿𝘀, 𝗰𝗹𝗶𝗻𝗶𝗰𝗶𝗮𝗻𝘀, 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗽𝘂𝗯𝗹𝗶𝗰 to spotlight the importance of breast health, early detection, and empowering women through knowledge.

🎗 At our booth, we shared the role of 𝗵𝗲𝗿𝗲𝗱𝗶𝘁𝗮𝗿𝘆 𝗰𝗮𝗻𝗰𝗲𝗿 𝗿𝗶𝘀𝗸 𝗮𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 in helping individuals understand their genetic predisposition — supporting more informed choices in 𝗵𝗲𝗮𝗹𝘁𝗵 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗮𝗻𝗱 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝘃𝗲 𝗰𝗮𝗿𝗲.

It was a day of shared strength, meaningful dialogue, and renewed commitment to women's health. Thank you to the 𝗕𝗲𝘀𝘁𝗔𝗥𝗶 𝗨𝗻𝗶𝘁 for the opportunity to contribute to such an impactful initiative.

12/01/2026

On 30th September 2025, Oncode had the privilege of engaging with the Oncology and Radiotherapy Department at Hospital Kuala Lumpur (HKL).

We shared how Oncode’s flexible and customisable panel options deliver high-quality molecular testing at accessible pricing—empowering clinicians with the tools they need for informed decision-making.

A key focus of the session was the critical role of genetic counselling in germline testing. At Oncode, all germline tests are paired with professional genetic counselling, ensuring patients receive not just results, but the support and clarity needed to navigate them confidently.

06/01/2026

From decoding rare mutations to empowering patients with knowledge — 𝗚𝗖𝗔𝗗-𝗡𝗙𝗔𝗗 𝟮𝟬𝟮𝟱 reminded us why genetics is at the heart of precision care.

Oncode was proud to participate in the 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗖𝗼𝘂𝗻𝘀𝗲𝗹𝗹𝗼𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗗𝗮𝘆 & 𝗡𝗲𝘂𝗿𝗼𝗳𝗶𝗯𝗿𝗼𝗺𝗮𝘁𝗼𝘀𝗶𝘀 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗗𝗮𝘆 𝟮𝟬𝟮𝟱, held at 𝗣𝗲𝗿𝗱𝗮𝗻𝗮 𝗞𝘂𝗮𝗹𝗮 𝗟𝘂𝗺𝗽𝘂𝗿 𝗖𝗶𝘁𝘆 𝗖𝗲𝗻𝘁𝗿𝗲 on 𝟭𝟱–𝟭𝟲 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿, in support of the growing impact of 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝗰𝗼𝘂𝗻𝘀𝗲𝗹𝗹𝗶𝗻𝗴 𝗶𝗻 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗰𝗮𝗿𝗲.

The event brought together clinicians, genetic counsellors, patients, and students to explore how 𝗵𝗲𝗿𝗲𝗱𝗶𝘁𝗮𝗿𝘆 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 — from 𝗰𝗮𝗿𝗿𝗶𝗲𝗿 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 to 𝗽𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 — is reshaping care pathways and ethical considerations in practice.

🧬 At our booth, we showcased the power of 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗥𝗶𝘀𝗸 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 through our 𝗖𝗔𝗡𝗖𝗘𝗥𝗜𝗦𝗞® 𝗽𝗮𝗻𝗲𝗹 and 𝗿𝗮𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝘁𝗲𝘀𝘁𝘀, designed to provide 𝗲𝗮𝗿𝗹𝘆, 𝗮𝗰𝘁𝗶𝗼𝗻𝗮𝗯𝗹𝗲 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀.

☕ A highlight was our 𝗺𝗼𝗿𝗻𝗶𝗻𝗴 𝘁𝗲𝗮 𝘁𝗮𝗹𝗸 by Dr Muzhirah Aisha, sharing how 𝗪𝗵𝗼𝗹𝗲 𝗘𝘅𝗼𝗺𝗲 𝗦𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 (𝗪𝗘𝗦) uncovered a novel mutation, improving diagnostic clarity and guiding more precise, personalised care.

Thank you to everyone who stopped by, listened, and shared. Together, we’re shaping the future of 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝗮𝗻𝗱 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝗻 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮.

31/12/2025

Wishing you a healthy and peaceful year ahead.🫶🏻✨
May 2026 bring strength, healing, and calm to every day.🌿

— Oncode Scientific

24/12/2025

May this joyful season bring hope, health, and peace to us all ✨
Wishing you a Merry Christmas 🎄
— Oncode Scientific

12/12/2025

On 8th November 2025, we were honoured to take part in the 𝗟𝘂𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽: 𝗕𝗮𝗰𝗸 𝘁𝗼 𝗕𝗮𝘀𝗶𝗰𝘀, held in conjunction with 𝗟𝘂𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵.

The workshop emphasised how 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗽𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴 supports lung cancer care, from the foundations of histopathological evaluation to guiding treatment decisions based on driver mutations detected in advanced disease.

At Oncode Scientific, our mission is clear — to deliver 𝗮𝗰𝗰𝘂𝗿𝗮𝘁𝗲, 𝘁𝗶𝗺𝗲𝗹𝘆, 𝗮𝗻𝗱 𝗮𝗰𝗰𝗲𝘀𝘀𝗶𝗯𝗹𝗲 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 that empower physicians and improve outcomes. From 𝘁𝗶𝘀𝘀𝘂𝗲 𝘁𝗼 𝗹𝗶𝗾𝘂𝗶𝗱 𝗯𝗶𝗼𝗽𝘀𝘆, our lung cancer panels are built to support real-world clinical decisions.

Thank you to all the organisers and healthcare professionals who continue to champion education and innovation in cancer care.

25/11/2025

We had an incredible experience at the 𝟯𝟲𝘁𝗵 𝗔𝗻𝗻𝘂𝗮𝗹 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗼𝗳 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝟮𝟬𝟮𝟱 (𝗔𝗦𝗖𝗢𝗠𝗢𝗦 𝟮𝟬𝟮𝟱), engaging with oncologists, internal medicine physicians, surgeons, pathologists, researchers, and other healthcare professionals who share our passion for advancing cancer care. The conference offered a unique opportunity to explore cutting-edge diagnostics, therapeutics, and technologies shaping the future of oncology.

🧬 We were proud to participate in the poster presentation, sharing real-world findings from our 𝗡𝗚𝗦-𝗯𝗮𝘀𝗲𝗱 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 and highlighting how molecular insights guide personalised treatment decisions.

🤝 Our collaborations with pharmaceutical partners reflect a shared commitment to advancing precision oncology — from supporting clinical trials to developing companion diagnostics that enable faster, more informed treatment decisions.

🚀 Driven by continuous R&D, we’re expanding access to 𝗻𝗲𝘅𝘁-𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 and elevating the standard of 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 for patients across Malaysia.

A heartfelt thank you to everyone who visited and engaged with us — your passion inspires our mission to make precision cancer care more accessible and impactful.

14/11/2025

We will be at 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗖𝗼𝘂𝗻𝘀𝗲𝗹𝗹𝗼𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗗𝗮𝘆 𝟮𝟬𝟮𝟱 (𝗚𝗖𝗔𝗗 𝟮𝟬𝟮𝟱)! Drop by the Oncode booth to explore reliable genomic solutions for confident, informed clinical decisions.

Check out our morning tea break talk on 𝗛𝗼𝘄 𝗪𝗵𝗼𝗹𝗲 𝗘𝘅𝗼𝗺𝗲 𝗦𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 𝗥𝗲𝗳𝗶𝗻𝗲𝘀 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀, delivered by Dr. Muzhirah Aisha Haniffa.

📅 Date: 15 November 2025
⏰ Time: 8:00AM – 5:00PM
📍 Location: Pearl & Amethyst Hall, Perdana Hotel Kuala Lumpur

10/11/2025

As part of a collaborative continuing medical education (CME) session with Astellas, Oncode had the opportunity to engage with the enthusiastic 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗛𝗮𝗲𝗺𝗮𝘁𝗼𝗹𝗼𝗴𝘆 𝘁𝗲𝗮𝗺 𝗮𝘁 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹 𝗦𝘂𝗹𝘁𝗮𝗻 𝗔𝗯𝗱𝘂𝗹 𝗔𝘇𝗶𝘇 𝗦𝗵𝗮𝗵, 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝗶 𝗣𝘂𝘁𝗿𝗮 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮 (𝗛𝗦𝗔𝗔𝗦 𝗨𝗣𝗠) on 4th August 2025.

The session covered key insights into 𝗙𝗟𝗧𝟯 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻𝘀 (𝗙𝗟𝗧𝟯𝗺), the most common genetic alterations in 𝗔𝗰𝘂𝘁𝗲 𝗠𝘆𝗲𝗹𝗼𝗶𝗱 𝗟𝗲𝘂𝗸𝗲𝗺𝗶𝗮 (𝗔𝗠𝗟), and compared available testing methods, outlining their clinical applications and limitations. We underscored the need for 𝗿𝗮𝗽𝗶𝗱 𝘁𝘂𝗿𝗻𝗮𝗿𝗼𝘂𝗻𝗱 𝘁𝗶𝗺𝗲 in guiding timely, effective treatment, and showcased 𝗰𝗮𝘀𝗲 𝘀𝘁𝘂𝗱𝗶𝗲𝘀 highlighting the role of 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 in AML management.

The session also spotlighted the 𝗙𝗟𝗧𝟯𝗺 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗖𝗼𝗽𝗮𝘆 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 𝗯𝘆 𝗢𝗻𝗰𝗼𝗱𝗲 & 𝗔𝘀𝘁𝗲𝗹𝗹𝗮𝘀, providing 𝘀𝘂𝗯𝘀𝗶𝗱𝗶𝘀𝗲𝗱 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 for HSAAS UPM patients with relapsed or refractory AML.

Grateful for the meaningful discussions and shared commitment to advancing precision haematology.

24/10/2025

🌆 𝗢𝗻𝗰𝗼𝗱𝗲 𝗮𝘁 𝗡𝗕𝗶𝗼𝗦𝗛𝗢𝗪𝗖𝗔𝗦𝗘, 𝗜𝗗𝗘𝗖𝗦𝟮𝟱 𝗦𝗮𝗿𝗮𝘄𝗮𝗸 🌆

We are honoured to be part of 𝗡𝗕𝗶𝗼𝗦𝗛𝗢𝗪𝗖𝗔𝗦𝗘 𝟮𝟬𝟮𝟱, held in conjunction with 𝗜𝗗𝗘𝗖𝗦𝟮𝟱 in Sarawak — where innovators, researchers, and changemakers came together to reimagine the future of bioeconomy and technology.

We are also delighted to have our 𝗙𝗼𝘂𝗻𝗱𝗶𝗻𝗴 𝗖𝗘𝗢, 𝗔𝘀𝘀𝗼𝗰. 𝗣𝗿𝗼𝗳. 𝗗𝗿. 𝗦𝘂 𝗪𝗲𝗻 𝗟𝗶𝗺, invited as a speaker at 𝗜𝗗𝗘𝗖𝗦𝟮𝟱, where she delivered an inspiring reflection titled “Healing the Future City: Building Health Systems That Think, Adapt & Care.”

In her keynote, Dr. Lim reminded audiences that as nations race to build smarter and more connected cities, true progress cannot be measured by speed, scale, or technology alone — but by the health and well-being of the people who live within them.

She urged a redefinition of progress: from technology as a competition of advancement, to technology as an act of healing — one that restores balance between people, planet, and progress. Because the future city is not just smart — it must also be compassionate.

At Oncode, this belief forms the foundation of everything we do.

We are building technologies that heal, restore, and uplift humanity — systems that think intelligently, adapt naturally, and care deeply.

💡 “Technology is not about invention for its own sake, nor competition for prestige — its very reason to exist is to heal, restore, and uplift lives.” — 𝗔𝘀𝘀𝗼𝗰. 𝗣𝗿𝗼𝗳. 𝗗𝗿. 𝗦𝘂 𝗪𝗲𝗻 𝗟𝗶𝗺

We extend our heartfelt thanks to Bioeconomy Corporation for the kind invitation and for hosting us. We deeply value the opportunity to share our vision among fellow innovators and changemakers who are shaping a future where science and technology work hand in hand to improve lives.

19/10/2025

✨ Wishing everyone a bright and joyful Deepavali!

May this Festival of Lights remind us that even the smallest glow can illuminate the world. 🌠

Address

Lot 03-01, 3rd Floor. Hap Seng Business Park, No. 12, Persiaran Perusahaan, Unity Square. Seksyen 23, Shah Alam D. E.
Shah Alam
40300

Opening Hours

Monday	09:00 - 18:00
Tuesday	09:00 - 18:00
Wednesday	09:00 - 18:00
Thursday	09:00 - 18:00
Friday	09:00 - 18:00

Telephone

+60333100819

Website

http://www.oncodesc.com/

Alerts

Be the first to know and let us send you an email when Oncode Scientific Sdn Bhd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Oncode Scientific Sdn Bhd:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Shah Alam?

About Oncode

ONCODE Scientific Sdn Bhd was founded in 2015, by a strong knowledge-based management and operational team with the combination of more than 85 years of experience in the areas of medical diagnostics and scientific research. It’s aims to be a niche player specializing in Precision Medicine utilizing the techniques of Next Generation Sequencing (NGS), Sanger sequencing, Real-Time & Standard PCR technologies. The team comprises of scientists, geneticists, physicians, pharmacists, bioinformaticians and business veterans who aim to deliver the best quality and affordable molecular diagnostic solutions to the global community.

Oncode laboratory workflows and pipelines include internal and external validation quality controls for compliance with international standards of Good Laboratory Practice (GLP), ISO 15189, the Association for Molecular Pathology (AMP) and the College of American Pathologist (CAP).

The laboratory participates in external quality assurance and proficiency programs including the UK National External Quality Assurance System (UKNEQAS), The European Molecular Genetics Quality Network (EMQN) and the Royal College of Pathologists of Australasia (RCPA).

Oncode Mission

To provide quality diagnostic solutions to customers through the implementation of state-of-the-art laboratory setup designed to worldwide standards, recruitment of dedicated professionals and comprehensive reporting systems.

Oncode Objective

To be a regional one-stop molecular genetics solution center, delivering powerful diagnostic support and insight to medical professionals

关于恩可德

恩可德私人有限公司成立于2015年，由一支强大的知识型管理和运营团队组成，在医疗诊断和科学研究领域拥有超过85年的经验。它的目标是通过提供高科技的下一代基因测序(Next- Generation Sequencing, NGS), Sanger基因测序，实时和标准聚合酶链反(Polymerase-Chain Reaction，PCR) 技术，成为专注于精准医学的利基参与者。该团队由科学家，遗传学家,专科医生，药剂师，生物信息学家和商业资深人士组成，旨在为全球社区提供最优质，价格合理的分子诊断解决方案。

恩可德实验室工作流程和管道包括内部和外验证质量控制，以符合良好实验室规范(Good- Laboratory Practice, GLP)，国际标准化组织（ISO15189），分子病理学协会(Association of Molecular Pathology, AMP)和美国病理学家学会(College of American Pathologist, CAP)的国际标准。

该实验室参与外部质量保证和熟练程序，包括英国国家外部质量保证体系(United Kingdom National External Quality Assurance System, UKNEQAS)，欧洲分子遗传学质量网络(European Molecular Genetics Quality Network)和澳大利亚皇家病理学家学会(Royal College of Pathologists of Australasia, RCPA).

我们的使命

通过实施针对全球标准设计的最先进实验室设置，招聘专业人员和综合报告系统，为客户提供高质量的诊断解决方案。

我们的目标

成为区域性一站式分子遗传学解决方案中心，为医疗专业人员提供强大的诊断支持和洞察力